LISA ISAACS: Open Payments
NPI 1285936377 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$686 in 52 payments from 8 companies in 2025. Trend: 2023 $495 · 2024 $414 · 2025 $686
Food & beverage: $686
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $375 |
| PFIZER INC. | 3 | $65 |
| Novartis Pharmaceuticals Corporation | 4 | $60 |
| ARGENX US, INC. | 3 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| UCB, Inc. | 2 | $38 |
| Alexion Pharmaceuticals, Inc. | 1 | $32 |
| Cycle Pharmaceuticals Inc | 1 | $14 |
Products named: QULIPTA, UBRELVY, NURTEC ODT, KESIMPTA, VYVGART HYTRULO, HYQVIA, Rystiggo, ULTOMIRIS.
Industry payments across IN — which companies pay providers there.
